NCT00612495 - Endometrial Cancer - LOHP Alone and With 5FU | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

March 31, 2005

Conditions

Endometrial Cancer

Interventions

DRUG

oxaliplatin, 5 FU

"Oxaliplatin:130 mg/m² as a 2-hour intravenous (IV) infusion in 500 mL of 5% glucose solution on Day 1 and repeated every 3 weeks.~5-FU: following oxaliplatin administration, 1000 mg/m²/day as a continuous IV infusion from Day 1 to Day 4, repeated every 3 weeks."

Trial Locations (1)

Unknown

Sanofi-Aventis, Paris